Brand profile · Biotechnology Research

Hexima Limited (ASX:HXL)

Melbourne, Victoria-based Hexima Limited operates in Biotechnology Research. Ownership is publicly held; it publishes at hexima.com.au. It holds one address on record, all in Australia. The record counts 7 people. Tagged biotechnology. Its latest round on record is Debt financing, US$1.1M. It is listed alongside five similar brands, mostly in Biotechnology Research.

hexima.com.au LinkedIn

Profile live Public Company Founded 1998 1 office country US$ 1.1M Debt financing
Counted staff
7
self-reported band not used
Founded
1998
28 years
Legal entities
None matched
Office countries
1
1 address
Funding rounds
1
Debt financing · Aug 2009 · US$ 1.1M
Company type
Public Company
self-reported
Use this profile Compare Your shortlist

Description

Hexima is a clinical stage, anti-infectives focused biotechnology company engaged in the research and development of plant defensin peptides for applications as human therapeutics. Our lead product candidate, pezadeftide (formally HXP124) applied in a topical formulation, is a potential new prescription treatment for toenail fungal infections (or onychomycosis). Hexima is currently conducting an Australian phase IIb clinical trial testing pezadeftide for the treatment of onychomycosis. Hexima holds granted, long-life patents protecting pezadeftide in major markets globally.

Specialties

All 4 specialties
  • Biotechnology
  • Fungal Pathogens
  • Antifungal peptides
  • Onychomycosis

Locations

Australiaprimary

Country footprint

Offices in 1 countryCountry footprint: 1 country, primary AU. Codes: AU.1 countryprimary AUAU
Show as table
Countries1
Primary countryAU

All codes: AU

Addresses

  • AUMelbourne, Victoria 3086Primary

Grid intelligence Members

Funding

Last round · 9 August 2009US$ 1.1MDebt financing · investor: Government of South Australia
Rounds1
Round typeDebt financing · non-equity funding
Amount (USD)1,100,000
Stage ranknot recorded
Investors named1
Since last round16 yr 5 mo

Funding

1 funding roundFunding timeline. Latest round 9 Aug 2009: Debt financing, US$ 1.1M.19982026Debt financingUS$ 1.1M1 round
Show as table
Rounds1
Axis1998 to 2026
Debt financing · 9 Aug 2009US$ 1.1M

Dated rounds only. The axis ends at the date this profile was last observed, not at today.

Spending power

TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.

Spending power

Notify me about spending power

Signals & hiring

Hiring, headcount and registry-change signals, streamed to members.

Latest signal
Hiring activity
Headcount trend
Notify me about signals

Financials

Registry-filed capital and financial indicators, standardised by TheGrid.

Paid-up capital
Fiscal period
Registered charges
Revenue
Profit / loss
Notify me about financials

People & contacts

2 employee profiles on record · names withheld.

Counts only. No names are stored here, and none are served.

Notify me about contacts Tell us who you need to reach and we will tell you when a consented source is live.

FAQ

How many people work at Hexima Limited (ASX:HXL)?

The record holds 7 counted staff profiles at January 2026. Its self-reported band sits above that count and is not published as a headcount.

Where does Hexima Limited (ASX:HXL) have offices?

One address on record, Australia only. Primary: Melbourne, Victoria 3086.

Has Hexima Limited (ASX:HXL) raised funding?

One round. Latest 9 August 2009: debt financing, US$1,100,000, investor Government of South Australia.

What does Hexima Limited (ASX:HXL) list as its specialties?

Four tags on the brand's own list, among them biotechnology.

Which companies are listed alongside Hexima Limited (ASX:HXL)?

Five peer profiles on record: Arovella Therapeutics ASX: ALA and Incannex Healthcare Inc.

What is Hexima Limited (ASX:HXL)'s website?

hexima.com.au